Here's Why Vertex Pharmaceuticals (VRTX) Gained But Lagged the Market Today

Investors will be eagerly watching for the performance of Vertex Pharmaceuticals in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on August 1, 2024. The company is expected to report EPS of $4.14, up 6.43$2.64 billion, indicating a 6.01% increase compared to the same quarter of the previous year. The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), po ...